NKTR – nektar therapeutics (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NKTR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/26

02:13 pm

nktr

Rating for NKTR

Low Report

Rating for NKTR

Report

11/26

02:13 pm

nktr

Rating for NKTR

Low Report

Rating for NKTR

Report

11/26

01:29 pm

nktr

Rating for NKTR

Low Report

Rating for NKTR

Report

11/26

01:29 pm

nktr

Rating for NKTR

Low Report

Rating for NKTR

Report

11/26

09:11 am

nktr

Nektar Therapeutics (NASDAQ:NKTR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $102.00 price target on the stock.

Medium Report

Nektar Therapeutics (NASDAQ:NKTR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $102.00 price target on the stock.

Report

9/19

08:07 am

nktr

Nektar Therapeutics (NASDAQ:NKTR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $100.00 price target on the stock.

Medium Report

Nektar Therapeutics (NASDAQ:NKTR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $100.00 price target on the stock.

Report

9/19

04:21 am

nktr

Rating for NKTR

Medium Report

Rating for NKTR

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.